SPONSOR
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 1
Conditions studied: Advanced Solid TumorNon Small Cell Lung CancerCML, Chronic PhaseCML, Accelerated Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Advanced Solid Tumor, Non Small Cell Lung Cancer, CML, Chronic Phase, CML, Accelerated Phase.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jiangsu Hansoh Pharmaceutical Co., Ltd.
How many clinical trials has Jiangsu Hansoh Pharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumor, Non Small Cell Lung Cancer, CML, Chronic Phase. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jiangsu Hansoh Pharmaceutical Co., Ltd. research focus on?
Jiangsu Hansoh Pharmaceutical Co., Ltd. clinical trials span Advanced Solid Tumor, Non Small Cell Lung Cancer, CML, Chronic Phase, CML, Accelerated Phase. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jiangsu Hansoh Pharmaceutical Co., Ltd. clinical trial?
To participate in a Jiangsu Hansoh Pharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jiangsu Hansoh Pharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Jiangsu Hansoh Pharmaceutical Co., Ltd.
NCT05911464 Phase 1
Recruiting
A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors
Advanced Solid Tumor
NCT06926413 Phase 1
Recruiting
A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC
Non Small Cell Lung Cancer
NCT05367700 Phase 1
Recruiting
A Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
CML, Chronic Phase
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology